会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明授权
    • Preparation of functional polymers
    • 官能聚合物的制备
    • US07795355B2
    • 2010-09-14
    • US10591425
    • 2005-03-07
    • Krzyszlof MatyjaszewskiBrent S. SumerlinNicolay V. TsarevskyJames Spanswick
    • Krzyszlof MatyjaszewskiBrent S. SumerlinNicolay V. TsarevskyJames Spanswick
    • C08F8/30
    • C08F8/30C08F293/005C08F2438/01C08F2438/03
    • The process of the present invention is directed toward conducting highly selective, high yield post polymerization reactions on polymers to prepare functionalized polymers. An embodiment of the present invention comprises conducting click chemistry reactions on polymers. Preferably, the polymers were prepared by controlled polymerization processes. Therefore, embodiments of the present invention comprise processes for the preparation of polymers comprising conducting a click chemistry reaction on a functional group attached to a polymer, wherein the polymer has a molecular weight distribution of less than 2.0. The functional polymers may be prepared by converting an attached functional unit on the polymer thereby providing site specific functional materials, site specific functional materials comprising additional functionality, or chain extended functional materials. Embodiments of the process of the present invention include functionalization reactions, chain extensions reactions, to form mock copolymer linking reactions, and attaching side chains to form graft copolymers, for example.
    • 本发明的方法涉及在聚合物上进行高选择性,高收率的后聚合反应以制备官能化聚合物。 本发明的一个实施方案包括对聚合物进行点击化学反应。 优选地,通过受控聚合方法制备聚合物。 因此,本发明的实施方案包括制备聚合物的方法,包括在连接到聚合物上的官能团上进行点击化学反应,其中聚合物的分子量分布小于2.0。 官能聚合物可以通过在聚合物上转化附着的官能单元来制备,从而提供位点特异性功能材料,包含附加官能团的位点特异性功能材料或链延伸的功能材料。 本发明方法的实施方案包括例如官能化反应,延伸链反应,形成嵌段共聚物连接反应和连接侧链以形成接枝共聚物。
    • 2. 发明申请
    • PREPARATION OF FUNCTIONAL POLYMERS
    • 功能聚合物的制备
    • US20110060107A1
    • 2011-03-10
    • US12877589
    • 2010-09-08
    • Krzysztof MatyjaszewskiBrent S. SumerlinNicolay V. TsarevskyJames Spanswick
    • Krzysztof MatyjaszewskiBrent S. SumerlinNicolay V. TsarevskyJames Spanswick
    • C08F8/30
    • C08F8/30C08F293/005C08F2438/01C08F2438/03
    • The process of the present invention is directed toward conducting highly selective, high yield post polymerization reactions on polymers to prepare functionalized polymers. An embodiment of the present invention comprises conducting click chemistry reactions on polymers. Preferably, the polymers were prepared by controlled polymerization processes. Therefore, embodiments of the present invention comprise processes for the preparation of polymers comprising conducting a click chemistry reaction on a functional group attached to a polymer, wherein the polymer has a molecular weight distribution of less than 2.0. The functional polymers may be prepared by converting an attached functional unit on the polymer thereby providing site specific functional materials, site specific functional materials comprising additional functionality, or chain extended functional materials.Embodiments of the process of the present invention include functionalization reactions, chain extensions reactions, to form block copolymer linking reactions, and attaching side chains to form graft copolymers, for example.
    • 本发明的方法涉及在聚合物上进行高选择性,高收率的后聚合反应以制备官能化聚合物。 本发明的一个实施方案包括对聚合物进行点击化学反应。 优选地,通过控制聚合方法制备聚合物。 因此,本发明的实施方案包括制备聚合物的方法,包括在连接到聚合物上的官能团上进行点击化学反应,其中聚合物的分子量分布小于2.0。 官能聚合物可以通过在聚合物上转化附着的官能单元来制备,从而提供位点特异性功能材料,包含附加官能团的位点特异性功能材料或链延伸的功能材料。 本发明方法的实施方案包括例如官能化反应,延伸链反应,形成嵌段共聚物连接反应和连接侧链以形成接枝共聚物。
    • 9. 发明申请
    • BORONIC ACID-CONTAINING BLOCK COPOLYMERS FOR CONTROLLED DRUG DELIVERY
    • 用于控制药物递送的含硼酸的嵌段共聚物
    • US20100029545A1
    • 2010-02-04
    • US12534916
    • 2009-08-04
    • Brent S. SumerlinJennifer N. CambreDebashish Roy
    • Brent S. SumerlinJennifer N. CambreDebashish Roy
    • A61K38/28A61K47/30A61K9/14
    • A61K9/1273A61K9/1075A61K38/28C08F2/38
    • Polymeric nanoaggregate drug-delivery compositions including boron-containing copolymers are described. The drug-delivery compositions may further include a therapeutic agent comprising a nucleic acid, a polynucletide, a peptide, a polypeptide, a protein, a pharmaceutical or any combinations thereof. Methods for making the polymeric nanoaggregate compositions including at least one therapeutic agent (for example, insulin) as well as methods for administration of these compositions to mammals are also set forth. The disclosure also describes compositions and methods for controlled drug delivery. Further, polymeric nanoaggregate boron-containing compositions including insulin and methods for monitoring and regulating blood glucose levels of a mammal are also described. The disclosure also describes methods for treatment and/or control of diabetes mellitus by administering polymeric nanoaggregate boron-containing compositions including insulin to a mammal in need.
    • 描述了包含含硼共聚物的聚合物纳米颗粒药物递送组合物。 药物递送组合物可以进一步包括包含核酸,多核苷酸,肽,多肽,蛋白质,药物或其任何组合的治疗剂。 还提出了制备包含至少一种治疗剂(例如胰岛素)的聚合物纳米颗粒组合物的方法以及将这些组合物施用于哺乳动物的方法。 本公开还描述了用于受控药物递送的组合物和方法。 此外,还描述了包含胰岛素的聚合纳米颗粒含硼组合物以及用于监测和调节哺乳动物血糖水平的方法。 本公开还描述了通过向需要的哺乳动物施用包含胰岛素的聚合纳米颗粒含硼组合物来治疗和/或控制糖尿病的方法。